Estabrook Capital Management’s Guardant Health GH Stock Holding History

Estabrook Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-51	Closed	-$2.17K	–	337
2025 Q1	$2.17K	Hold	51	–	–	﹤0.01%	305
2024 Q4	$1.56K	Hold	51	–	–	﹤0.01%	323
2024 Q3	$1.17K	Hold	51	–	–	﹤0.01%	340
2024 Q2	$1.47K	Hold	51	–	–	﹤0.01%	326
2024 Q1	$1.05K	Hold	51	–	–	﹤0.01%	340
2023 Q4	$1.38K	Hold	51	–	–	﹤0.01%	340
2023 Q3	$1.51K	Hold	51	–	–	﹤0.01%	349
2023 Q2	$1.83K	Hold	51	–	–	﹤0.01%	360
2023 Q1	$1.2K	Hold	51	–	–	﹤0.01%	381
2022 Q4	$1.39K	Hold	51	–	–	﹤0.01%	391
2022 Q3	$2.75K	Hold	51	–	–	﹤0.01%	364
2022 Q2	$2.06K	Hold	51	–	–	﹤0.01%	396
2022 Q1	$3.38K	Hold	51	–	–	﹤0.01%	377
2021 Q4	$5.1K	Buy	+51	New	+$5.28K	﹤0.01%	371

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Estabrook Capital Management's GH Position: Q2 2025 in Review

Estabrook Capital Management sold out of Guardant Health (GH) in Q2 2025, closing a stake of 51 shares — an estimated $2.17K sold.

Estabrook Capital Management first reported a position in GH in Q4 2021 and held it in 14 quarters. The position peaked at $5.1K in Q4 2021. 365 funds tracked by Wall St. Rank hold GH as of Q2 2025.

Estabrook Capital Management reported no remaining Guardant Health position as of Q2 2025 after selling out during the quarter.
Estabrook Capital Management sold 51 Guardant Health shares in Q2 2025, an estimated $2.17K.
Estabrook Capital Management first reported a position in Guardant Health in Q4 2021 and held it in 14 quarters.
Estabrook Capital Management's Guardant Health position peaked at $5.1K in Q4 2021.
365 funds tracked by Wall St. Rank held Guardant Health as of Q2 2025.

Based on Estabrook Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.